日本到2030年将全面取消纸质入关申报 原创 阅读全文 日经GO ...

24 June 2026 | 7:00AM CST Equity Research CHINA MOBILITY TECH Revisiting cyclical framework: industry consolidation unlikely in near term, momentum of earnings cuts accelerating We revisit our cyclical framework for the China OEM space amid a sharply declining domestic market (volumes -19% YTD), partially offset by a strong acceleration in exports (+70% YTD). Our framework requires three parameters to be hit for industry consolidation to happen: (1) OEMs at cash cost level; (2) management capitulating on pr ...

The 720: China & Global Autos, Kioxia, Tencent, Servers, China Spirits, JP Aerospace & Defense, Iluka Resources, Henderson Land 24 June 2026 | 7:19AM HKT Equity Research Global Automobiles – Clear sign of re-electrification. We see clear signs of re-electrification as the global BEV sales mix rose to 19% in May from 13% in February, driven by Middle East instability and rising gasoline prices. The shift is stabilizing price competition, increasing market share for Chinese BEV manufacturers, and prompting Eu ...

24 June 2026 | 6:17AM IST Equity Research Tata Motors Passenger Vehicles Ltd. (TAMO.BO): TMPV Investor Day: Fast growth aspirations; Cannibalization + EV competition represent Kota Yuzawa +81(3)4587-9863 | kota.yuzawa@gs.com Goldman Sachs Japan Co., Ltd. TAMO.BO held its 2026 Domestic business Investor Day on June 23. Over FY26 -FY29, the company expects the TAMO domestic business (~50% of SOTP value) deliver more than 25%/32%/ 44% 3-year-fwd Revenue/EBITDA/PBT CAGRs. These aspirations are underpinned by TA ...

24 June 2026 | 2:14AM CEST Equity Research Kuehne & Nagel (KNIN.S) Q2+Q3 preview: We see 6-10% upside to consensus numbers over the coming quarters KNIN.S 12m Price Target: SFr230.00 Price: SFr183.95 Upside: 25.0% 10% ahead on Q2 EBIT, and see further upgrades likely for Q3/FY26 Since turning more constructive on K+N earlier this year, we've had an above consensus near-term earnings view rooted in a) mean-reversion in Air & Sea margins from a 25Y low supported by cost-cutting; b) US inventory cycle inflecti ...

24 June 2026 | 9:05AM HKT Equity Research CARsgen Therapeutics (2171.HK): On-time approval of satri-cel marks the first CAR-T for solid tumor Satri-cel China approval for 3L+ GC: On Jun 22nd, CARsgen announced the approval of satri-cel (CT041, CLDN18.2 CAR-T) by the NMPA for the treatment of patients with Claudin18.2-positive (IHC 2+ ≥40%), HER2-negative advanced gastric/ gastroesophageal junction adenocarcinoma (G/GEJA) who have failed at least two prior lines of therapy, which is based on ph2 China data f ...

24 June 2026 | 8:09AM JST Equity Research Panasonic HD (6752.T): Reported supercapacitor production ramp: BBU/CBU combo could lift competitiveness/increase external sales The Nikkei report on June 23 that Panasonic HD's subsidiary Panasonic Industry plans to ramp up production of supercapacitors (LINK). Generative AI data centers require products that can cope with unique fluctuations and sudden increases in power consumption (peak shaving). Panasonic holds a c. 80% global market share (per the Nikkei) in b ...

24 June 2026 | 1:38AM GST Equity Research Novonesis (NSISb.CO): Household Care Spotlight Session Today (23 June), Novonesis hosted a virtual educational session on the company's Household Care division (19% of group Sales). The event was presented by Tina Sejersgård Fanø (EVP Planetary Health Biosolutions), Jens Kolind (SVP Planetary Health Biosolutions / Household Care) and Henrik Funder (Head of Household Care Marketing). The event highlighted how Novonesis is positioned to sustainably outgrow the global ...

24 June 2026 | 9:19AM KST Equity Research Hyundai M&F (001450.KS): Asia Financials Corporate Day takeaways We hosted Hyundai M&F (HMF) at our Asia Financial Corporate Day on June 23rd, 2026. Given the weak 1Q print and scheduled regulatory guidelines, discussions centered on underwriting cycles, reform initiatives, and the path to dividend resumption. Expecting an improving underwriting cycle ahead, aided by reform initiatives While top-line trends could remain sluggish following premium hikes and given the ...

24 June 2026 | 12:37AM BST Equity Research Essity (ESSITYb.ST) Oil relief lifts forecasts, but margin risks persist; Neutral ESSITYb.ST 12m Price Target: Skr270.00 Price: Skr270.40 Downside: 0.1% Oil relief lifts our forecasts, does not resolve the near-term margin debate. Since our last update, oil prices have fallen 30%, easing pressure across petrochemical, energy, and fuel inputs, while pulp prices have continued to edge modestly higher. On balance, we now expect mid-single-digit unit cost inflation in ...